CSL Limited Sponsored ADR (OTCMKTS:CSLLY – Get Free Report)’s share price was down 2.4% on Friday . The company traded as low as $70.00 and last traded at $70.42. Approximately 199,268 shares changed hands during mid-day trading, an increase of 260% from the average daily volume of 55,416 shares. The stock had previously closed at $72.13.
CSL Stock Down 2.4%
The business’s 50-day moving average price is $82.11 and its 200 day moving average price is $80.27. The company has a current ratio of 1.86, a quick ratio of 0.85 and a debt-to-equity ratio of 0.45.
CSL Company Profile
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Further Reading
- Five stocks we like better than CSL
- Airline Stocks – Top Airline Stocks to Buy Now
- Costco and Ross: 2 Ways to Play the Consumer Divide
- What is the Nasdaq? Complete Overview with History
- Is Paramount Skydance a Buy Post-Merger, Short Squeeze?
- Growth Stocks: What They Are, What They Are Not
- V2X Stock: Defense Underdog Riding a $4.3B Air Force Contract
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
